Osteoporosis is a condition that makes bones weak and brittle, especially common in older adults. The discovery of lead compounds for anti-osteoporosis drugs from marine organisms is a significant advancement because they may offer new treatment options to help prevent or slow down the progression of osteoporosis. These drugs might have unique mechanisms of action different from existing medications, providing patients with more treatment choices, reducing fracture risk, and improving quality of life.